Physician profile
Sonam Singh
NPI 1609288372
$3,203.41
in general payments reported to CMS, 2019-2025
13 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,351 · 2020: $11.28 · 2021: $258 · 2022: $337 · 2023: $212 · 2024: $770 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,245.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,350.59 | 2019 | |
| Becton, Dickinson and Company | $272.99 | 2024-2025 | Arista Ah Flexitip, Bd Onclarity |
| Organon LLC | $269.47 | 2024 | |
| Coopersurgical, INC. | $258.07 | 2020-2022 | |
| Hologic Sales and Service, LLC | $232.57 | 2024 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Olympus America INC. | $189.83 | 2021 | |
| Gynesonics, INC. | $124.99 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Vertex Pharmaceuticals Incorporated | $120.36 | 2025 | |
| Roche Diagnostics Corporation | $106.08 | 2023 | Cobas 4800 Ct/Ng Test V2.0 |
| Viiv Healthcare Company | $105.44 | 2023 | Apretude |
| Abbvie INC. | $90.43 | 2022 | |
| Medtronic, INC. | $68.52 | 2021 | |
| Ethicon US, LLC | $14.07 | 2025 | Vistaseal, Surgiflo Hemostatic Matrix, Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonam Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.